There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Vertex (VERX – Research Report) and AppLovin ...

Stifel Nicolaus analyst Brad Reback maintained a Hold rating on Vertex (VERX – Research Report) today and set a price target of $31.00. The ...

Below is a table showing the current thinking of the analysts that cover Vertex Pharmaceuticals, Inc.: ...

Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq ...

Three Florida Tech students are making a mechanical 'spy' manatee to covertly learn sea cows' deepest secrets.

Vertex Pharmaceuticals is an innovative biotech ... That's why third-party payers have increasingly opted to cover them. Yet, even in the U.S., the percentage of CGM users trails the covered ...

We have two types of hair, says dermatologist Elizabeth Houshmand. Vellus hairs, or “peach fuzz,” cover virtually our entire ...

It's worth mentioning that the Orum deal comes as Vertex has sued the US Government for failing to cover a fertility support programme for Casgevy, for example freezing and storing eggs.

Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.

Markel, the insurance operations within Markel Group Inc. , today announced that it has made three internal promotions and hired a Technical Claims Lead to further enhance its award-winning Wholesale ...

Vertex' portfolio has been steadily expanded with new product launches to cover the majority of CF mutations, and so it has been looking at new therapeutic categories – including T1D ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Argenx Se (ARGX – Research Report). The company’s shares closed yesterday at $619.97. Lig ...